Executive Summary
ControlTec requests the PTAB Director to overturn the institution of an IPR on its expired ’847 patent, arguing that the patent’s long life creates strong settled expectations and that the cited Carter reference was already deemed non‑material. The petition seeks discretionary denial under § 314(a).
Related Cases
PacifiCorp et al.vsMES, Inc.
WEC Energy Group and Birchtech Corp have settled their dispute over U.S. Patent 10,933,370, filing a joint motion to terminate the inter partes review. The motion cites settlement, lack of a merits decision, and public‑policy benefits of settlement.
SAMSUNG ELECTRONICS CO., LTD. et al.vsiCashe, Inc.
The USPTO denied Samsung’s request for Director Review of the institution denial in the iCashe payment‑system IPR. The Board affirmed the original decision not to institute the case.
Samsung Electronics Co., Ltd. et al.vsOura Health Oy et al.
The PTAB denied Samsung's IPR petition against Oura Health because the patent owner had statutorily disclaimed all challenged claims.
Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.
Merck has filed a post‑grant review petition challenging Halozyme’s U.S. Patent 12,371,685 covering modified PH20 hyaluronidase proteins, asserting lack of written description and enablement.
Apple Inc.vsResonant Systems, Inc.
The Board issued a Final Written Decision finding all five claims unpatentable under 35 U.S.C. § 103(a). The Petitioner successfully demonstrated that the claimed invention was obvious over various combinations of prior art references, including Izumi and Cosper.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.